Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2019 1
2021 5
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.
Paton NI, Musaazi J, Kityo C, Walimbwa S, Hoppe A, Balyegisawa A, Asienzo J, Kaimal A, Mirembe G, Lugemwa A, Ategeka G, Borok M, Mugerwa H, Siika A, Odongpiny ELA, Castelnuovo B, Kiragga A, Kambugu A; NADIA Trial Team. Paton NI, et al. Lancet HIV. 2022 Jun;9(6):e381-e393. doi: 10.1016/S2352-3018(22)00092-3. Epub 2022 Apr 20. Lancet HIV. 2022. PMID: 35460601 Free article. Clinical Trial.
The Joint Mobile Emerging Disease Clinical Capability (JMEDICC) laboratory approach: Capabilities for high-consequence pathogen clinical research.
Naluyima P, Kayondo W, Ritchie C, Wandege J, Kagabane S, Tumubeere L, Kusiima B, Kibombo D, Atukunda S, Nanteza C, Nabirye H, Mugabi FB, Namuyanja S, Hatcher C, Rauch H, Mukembo M, Musinguzi P; JMEDICC Consortium; Sanders N, Turesson E, Cando C, Walwema R, Mimbe D, Hepburn J, Clark D, Lamorde M, Kibuuka H, Zaman S, Cardile AP, Martins KA. Naluyima P, et al. Among authors: wandege j. PLoS Negl Trop Dis. 2019 Dec 19;13(12):e0007787. doi: 10.1371/journal.pntd.0007787. eCollection 2019 Dec. PLoS Negl Trop Dis. 2019. PMID: 31856153 Free PMC article. Review.
Routine HIV clinic visit adherence in the African Cohort Study.
Dear N, Esber A, Iroezindu M, Bahemana E, Kibuuka H, Maswai J, Owuoth J, Polyak CS, Ake JA, Crowell TA; AFRICOS Study Group. Dear N, et al. AIDS Res Ther. 2022 Jan 7;19(1):1. doi: 10.1186/s12981-021-00425-0. AIDS Res Ther. 2022. PMID: 34996470 Free PMC article.
Safety, tolerability, and immunogenicity of the Ebola Sudan chimpanzee adenovirus vector vaccine (cAd3-EBO S) in healthy Ugandan adults: a phase 1, open-label, dose-escalation clinical trial.
Mwesigwa B, Houser KV, Hofstetter AR, Ortega-Villa AM, Naluyima P, Kiweewa F, Nakabuye I, Yamshchikov GV, Andrews C, O'Callahan M, Strom L, Schech S, Anne Eller L, Sondergaard EL, Scott PT, Amare MF, Modjarrad K, Wamala A, Tindikahwa A, Musingye E, Nanyondo J, Gaudinski MR, Gordon IJ, Holman LA, Saunders JG, Costner PJM, Mendoza FH, Happe M, Morgan P, Plummer SH, Hickman SP, Vazquez S, Murray T, Cordon J, Dulan CNM, Hunegnaw R, Basappa M, Padilla M, Gajjala SR, Swanson PA 2nd, Lin BC, Coates EE, Gall JG, McDermott AB, Koup RA, Mascola JR, Ploquin A, Sullivan NJ, Kibuuka H, Ake JA, Ledgerwood JE; RV 508 Study Team. Mwesigwa B, et al. Lancet Infect Dis. 2023 Dec;23(12):1408-1417. doi: 10.1016/S1473-3099(23)00344-4. Epub 2023 Aug 3. Lancet Infect Dis. 2023. PMID: 37544326 Clinical Trial.
Dolutegravir or Darunavir in Combination with Zidovudine or Tenofovir to Treat HIV.
Paton NI, Musaazi J, Kityo C, Walimbwa S, Hoppe A, Balyegisawa A, Kaimal A, Mirembe G, Tukamushabe P, Ategeka G, Hakim J, Mugerwa H, Siika A, Asienzo J, Castelnuovo B, Kiragga A, Kambugu A; NADIA Trial Team. Paton NI, et al. N Engl J Med. 2021 Jul 22;385(4):330-341. doi: 10.1056/NEJMoa2101609. N Engl J Med. 2021. PMID: 34289276 Clinical Trial.
Transient Reductions in Human Immunodeficiency Virus (HIV) Clinic Attendance and Food Security During the Coronavirus Disease 2019 (COVID-19) Pandemic for People Living With HIV in 4 African Countries.
Dear N, Duff E, Esber A, Parikh A, Iroezindu M, Bahemana E, Kibuuka H, Owuoth J, Maswai J, Crowell TA, Ake JA, Polyak CS; AFRICOS Study Group. Dear N, et al. Clin Infect Dis. 2021 Nov 16;73(10):1901-1905. doi: 10.1093/cid/ciab379. Clin Infect Dis. 2021. PMID: 33906235 Free PMC article.
Epidemiology of Tuberculosis Among People Living With HIV in the African Cohort Study From 2013 to 2021.
Ganesan K, Mwesigwa R, Dear N, Esber AL, Reed D, Kibuuka H, Iroezindu M, Bahemana E, Owuoth J, Singoei V, Maswai J, Parikh AP, Crowell TA, Ake JA, Polyak CS, Shah N, Cavanaugh JS; AFRICOS Study Group; AFRICOS Study Group. Ganesan K, et al. J Acquir Immune Defic Syndr. 2023 Apr 15;92(5):359-369. doi: 10.1097/QAI.0000000000003152. Epub 2023 Jan 3. J Acquir Immune Defic Syndr. 2023. PMID: 36728618 Free PMC article.
12 results